STAAR Surgical Company (STAA) - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on January 6, 2026, by STAAR Surgical Company, a Delaware corporation. The report details the conclusion of a special meeting of stockholders held on the same date to vote on proposals related to a proposed merger.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance events regarding a merger.
Material Changes and Events
- Merger Proposal: The Company held a special meeting to consider the Agreement and Plan of Merger dated August 4, 2025, between STAAR Surgical, Alcon Research, LLC ("Alcon"), and Rascasse Merger Sub, Inc.
- Agreement Amendments: The Merger Agreement was amended twice prior to the vote: Amendment No. 1 on November 7, 2025, and Amendment No. 2 on December 9, 2025.
- Voting Results: The Company announced preliminary voting results of the Special Meeting via a press release attached as Exhibit 99.1. The specific outcome of the vote (approval or rejection) is not detailed in the body of this 8-K text.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future operations, or specific risk factors beyond the context of the pending merger transaction. The primary contingency is the finalization of the merger based on the stockholder vote results referenced in the attached press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) to confirm the final voting results and whether the merger was approved by stockholders.
- Verify the specific terms of the merger, including the exchange ratio or cash consideration, in the original Merger Agreement and its amendments.
- Monitor subsequent filings for the definitive merger agreement or termination notices if the vote was not successful.
- Check for any regulatory approvals required from the FTC or other bodies to consummate the transaction with Alcon.